Compare ANNX & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANNX | SHBI |
|---|---|---|
| Founded | 2011 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 873.3M | 757.4M |
| IPO Year | 2020 | 1997 |
| Metric | ANNX | SHBI |
|---|---|---|
| Price | $4.14 | $23.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $16.50 | ★ $19.17 |
| AVG Volume (30 Days) | ★ 2.5M | 135.8K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.51% |
| EPS Growth | N/A | ★ 34.85 |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $20,853,000.00 |
| Revenue This Year | N/A | $8.97 |
| Revenue Next Year | $16,320.74 | $6.26 |
| P/E Ratio | ★ N/A | $21.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.32 | $14.93 |
| 52 Week High | $7.18 | $24.89 |
| Indicator | ANNX | SHBI |
|---|---|---|
| Relative Strength Index (RSI) | 27.78 | 49.18 |
| Support Level | $4.01 | $22.47 |
| Resistance Level | $5.63 | $23.68 |
| Average True Range (ATR) | 0.24 | 0.49 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 6.64 | 76.19 |
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.
Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.